PharmacoEconomics and Outcomes News

US health insurers guilty of performing the old switcheroo?
pp. 1-1(1)

Latest recommendations from UK NICE
pp. 2-2(1)

The mass vaccination campaign against meningitis A using MenAfriVac is to start on 6 December in Burkina Faso.
pp. 2-2(1)

WHO implores all countries to improve health financing
pp. 2-2(1)

Pharmac announces new funding decisions
pp. 3-3(1)

£300 million wasted on drugs each year in England
pp. 3-3(1)

Is the current evidence on Medicare part D sufficient?
pp. 3-3(1)

Diabetes care still a postcode lottery in the UK
pp. 4-4(1)

Productivity gains recommended to the UK's mental health services
pp. 4-4(1)

No "magic bullet" when it comes to universal healthcare
pp. 4-4(1)

Artesunate: a cost-effective stop-gap when facilities are scarce
pp. 5-5(1)

Infliximab for IBD: clinical benefits at acceptable costs
pp. 5-5(1)

Noncompliance with therapy a serious issue in schizophrenia
pp. 5-5(1)

News from ACR/ARHP
pp. 6-7(2)

Obesity intervention "very effective" in reducing drug costs
pp. 7-7(1)

Antiretroviral coverage in Africa improved by donors and price cuts
pp. 8-8(1)

Global Polio Eradication Initiative justified
pp. 8-8(1)

Immediate treatment tops monitoring for small HCC
pp. 8-8(1)

Imiquimod or photodynamic therapy for actinic keratosis?
pp. 9-9(1)

Integrated care for low back pain a winner all round
pp. 9-9(1)

Vitamin C and E use during pregnancy not worthwhile
pp. 9-9(1)

Prescribing quality in the USA comes at a price, or does it?
pp. 9-9(1)

From 2011, doctors in Spain will be able to prescribe the exact number of pills a patient requires, in a move to save €300 million.
pp. 10-10(1)

The potential of telehealth in Australia
pp. 10-10(1)

Pre-op dexamethasone improves post-op QOL
pp. 10-10(1)

H. pylori infections "less common but more expensive"
pp. 10-10(1)

Amifampridine revision "an awfully long time to wait"
pp. 11-11(1)

Average medical unit costs "once again" highest in US
pp. 11-11(1)